Goldschmidt is Vice President and Principal at Genesis Engineers Inc. He has nearly 30 years of experience in engineering management, planning, design and construction in the pharmaceutical and biotech industry.
Prior to joining Genesis, Norman served in numerous capacities during 20 years with Bristol-Myers Squibb (BMS), culminating as Executive Director, Global En-gineering. His industry experience spans the many types of facilities and processes necessary to bring a drug to market, from R&D through manufacturing.
Goldschmidt holds 4 patents for innovations in HVAC and Pharmaceutical Processing, is an International Standards Organization (ISO) delegate, Adjunct Professor at the New Jersey Institute of Technology, and Lead Author of the ISPE Good Practice Guide for HVAC. He is also an author, contributor, and instructor for ISPE, ASHRAE, NSF, and others.
Do you know what you think you know about US/EU cleanroom classifications, HEPA efficiency, and air change rules of thumb? And what does that leak really mean for performance? Read on for further tales from the road to science-based environmental control in biopharmaceutical facilities.
bad news is that energy efficiency has understandably never been job
one in the pharmaceutical industry. The good news is that
opportunities abound for real progress as a new emphasis on
sustainability grows. The author offers more than a daily dose of
industry-specific insight while outlining why higher efficiency need
not be a bitter pill to swallow.
A few circumstances in a data center make it ripe for a CHP design to boost efficiency. Let’s get into the options within both relevant chiller types, why payback may be shorter than expected, and the assorted potential benefits from lower costs to higher reliability. Some tips from an array of manufacturers’ reps round out this useful investigation.